Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Sale −3,048 $35.51 $108K 70,207
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Sale −847 $36.38 $31K 69,360
2021-05-06 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 128,535
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Sale −3,895 $35.43 $138K 69,360
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 132,430
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Sale −3,195 $35.43 $113K 69,360
2021-05-05 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 132,430
2021-05-04 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-05-04 ROBINS HARLAN S Chief Scientific Officer Sale −3,195 $35.99 $115K 70,060
2021-05-04 ROBINS HARLAN S Chief Scientific Officer Sale −700 $36.80 $26K 69,360
2021-05-04 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 136,325
2021-04-30 Taylor Stacy L SVP and General Counsel Option exercise +1,042 $7.80 $8K 16,078
2021-04-30 Taylor Stacy L SVP and General Counsel Option exercise +1,770 $6.55 $12K 17,848
2021-04-30 Taylor Stacy L SVP and General Counsel Option exercise +1,354 $31.71 $43K 19,202
2021-04-30 Taylor Stacy L SVP and General Counsel Sale −4,166 $41.93 $175K 15,036
2021-04-30 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,042 25,000
2021-04-30 Taylor Stacy L SVP and General Counsel Option exercise · Stock Option (Right to Buy) −1,770 19,480

Page 48 of 120 · 2,386 trades